{"name": "Recipharm",
 "permalink": "recipharm",
 "crunchbase_url": "http://www.crunchbase.com/company/recipharm",
 "homepage_url": "http://www.recipharm.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1995,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "46 86 02 52 00",
 "description": "",
 "created_at": "Tue Sep 15 15:04:21 UTC 2009",
 "updated_at": "Tue Sep 15 15:04:21 UTC 2009",
 "overview": "\u003Cp\u003ERecipharm AB operates as a pharmaceutical contract development and manufacturing company. Its dosage forms include solid dose, steriles, semi solids, beta-lactams, hormones, dry powder inhalers, granulates, and powders. The company provides pharmaceutical development services, such as formulation development, clinical supplies, analytical development, stability studies, packaging development and selection, and raw material selection; and manufacturing services. It also offers EU gateway release and testing, regulatory, stability studies, and customized services. Recipharm AB was founded in 1995 and is based in Haninge, Sweden. It has manufacturing facilities in Sweden, France, and the United Kingdom.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       67],
      "assets/images/resized/0005/9832/59832v1-max-150x150.jpg"],
     [[194,
       87],
      "assets/images/resized/0005/9832/59832v1-max-250x250.jpg"],
     [[194,
       87],
      "assets/images/resized/0005/9832/59832v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Thomas",
      "last_name": "Eldered",
      "permalink": "thomas-eldered",
      "image": null}},
   {"is_past": false,
    "title": "Vice President of Science \u0026 Technology ",
    "person":
     {"first_name": "Sture",
      "last_name": "Nordberg",
      "permalink": "sture-nordberg",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "",
    "source_description": "Cap Funding Report",
    "acquired_year": 2008,
    "acquired_month": 11,
    "acquired_day": 17,
    "company":
     {"name": "AstraZeneca Biotech Laboratory",
      "permalink": "astrazeneca-biotech-laboratory",
      "image": null}}],
 "offices":
  [{"description": "",
    "address1": "Lagervagen 7",
    "address2": "",
    "zip_code": "136 50",
    "city": "Haninge",
    "state_code": null,
    "country_code": "SWE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}